"Is the Janssen deal simply conditional on successfully filing patent protection?"
Wonderful question. Phylogica has identified a panel of FPPs. Does each one of those FPPs require specific patent protection or are they covered under an existing class patent already held by Phylogica?
Enumerate,
You appear to suggest that formal patent acceptance of the FPPs for 'therapeutic use' is required.
- Forums
- ASX - By Stock
- endosomal escape patents
PYC
pyc therapeutics limited
Add to My Watchlist
3.03%
!
$1.28

"Is the Janssen deal simply conditional on successfully filing...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.28 |
Change
-0.040(3.03%) |
Mkt cap ! $746.5M |
Open | High | Low | Value | Volume |
$1.32 | $1.35 | $1.28 | $764.7K | 579.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 4000 | $1.28 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.30 | 40248 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 4000 | 1.275 |
1 | 13987 | 1.265 |
2 | 16060 | 1.260 |
1 | 12000 | 1.255 |
2 | 2800 | 1.250 |
Price($) | Vol. | No. |
---|---|---|
1.300 | 40248 | 3 |
1.330 | 5000 | 1 |
1.345 | 53113 | 2 |
1.350 | 22000 | 2 |
1.360 | 5958 | 1 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online